ASN Policy Priorities

“The 2018 MACRA proposed rule was the first draft with Price’s involvement after he emphasized that he wanted to reduce reporting burdens and allow clinicians to focus on patient care. His rhetoric proved true as the proposed rule excluded more clinicians from having to participate while also making it easier to avoid a penalty.

Now that he is gone, what will happen to the final rule that is set to be released in November 2017?

How will clinicians plan for 2018… without a solid MACRA rule in place?

American Society of Nephrology (ASN) President Eleanor D. Lederer, MD, FASN, wrote to Senate Majority Leader Mitch McConnell (R-KY) and Minority Leader Charles E. Schumer (D-NY) today expressing ASN’s strong objections to the Graham-Cassidy health care proposal under consideration in the US Senate this week.

Investing in kidney research is crucial to improving clinical outcomes of Americans with kidney disease and the cost-effectiveness of kidney care.

Please bolster kidney research funding by an additional $1.5 billion ($150 million over 10 years) for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH).

Every day ASN volunteers and staff address the most critical issues in healthcare on behalf of patients with kidney disease and the professionals who advance their care. Learn more about issues at the top of ASN's priority list here. These priorities include pushing forward the Living Donor Protection Act, helping legislators understand why more funding for kidney research is vital to improving care, and crafting policies that will improve care of patients with chronic diseases.